Jacobson Pharma Corporation Limited (2633.HK) HKSE
1.15
+0.02(+1.77%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 2.34B |
| Enterprise Value | 2.61B |
| P/E Ratio | 7.59 |
| PEG Ratio | 0.49 |
| Price/Sales Ratio | 1.5 |
| Price/Book Ratio | 1.03 |
| Enterprise/Revenue | 1.83 |
| Enterprise/EBITDA | 5.25 |
Fiscal Year
| Fiscal Year | March 31, 2025 |
| Most Recent Quarter | September 30, 2025 |
Profitability
| Profit Margin | 0.2 |
| Operating Margin | 0.24 |
Management Effectiveness
| Return On Assets | 0.09 |
| Return On Equity | 0.13 |
Income Statement
| Revenue | 1.58B |
| Revenue/Share | 0.77 |
| Gross Profit | 692.94M |
| EBITDA | 558.87M |
| Net Income | 300.83M |
| Diluted EPS | 0.15 |
Balance Sheet
| Total Cash | 395.06M |
| Total Cash/Share | 0.2 |
| Total Debt | 904.62M |
| Total Debt/Equity | 0.4 |
| Current Ratio | 1.41 |
| Book Value Per Share | 1.13 |
Price History
| 52-Week Change | -10.85 |
| 52-Week High | 1.78 |
| 52-Week Low | 1.11 |
| Moving Average 50 Days | 1.18 |
| Moving Average 200 Days | 1.31 |
Statistics
| Average Volume | 320,530 |
| Shares Outstanding | 2B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.16 |
| Trailing Annual Dividend Yield | 13.7 |
| Payout Ratio | 1.19 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
